Skip to main content

Table 2 Cell cycle in LNCaP cells

From: SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo

Cell cycle phase Control DHT SFRP1 SFRP1 + DHT Nocodazole
G1 75.6% ± 0.2 73.05% ± 2.2 77.21% ± 0.5 71.95% ± 3.1 79.31% ± 0.2
S 9.0% ± 0.1 12.04% ± 3.2 7.66% ± 0.3 12.76% ± 2.4 7.36% ± 0.2
G2 15.3% ± 0.3 14.91% ± 1.1 15.12% ± 0.1 15.29% ± 1.6 13.34% ± 0.07
  1. Data are the average ± s.d. of a representative experiment carried out in triplicate (*p < 0.005; Student’s t-test, of treatments compared to control (vehicle)